Rheumatoid arthritis begins years before pain ever appears, and scientists have now mapped the hidden immune battle that unfolds long before symptoms. By studying people with RA-linked antibodies over ...

Brookfield Real Assets Income Fund is downgraded to a sell due to persistent NAV decline and unsustainable dividend coverage. RA's high 10.7% yield is attractive, but earnings consistently fall short ...

You could one day be spared from ever experiencing the debilitating symptoms of rheumatoid arthritis (RA)—thanks to a new discovery that could help open the door to prevention. It seems RA doesn’t ...

1 Department of Laboratory Medicine, Shangyu People’s Hospital of Shaoxing, Shaoxing University, Shaoxing, China 2 Department of Laboratory Medicine, Wuxi Ninth People’s Hospital Affiliated to Soochow ...

Rosnilimab, a selective depleter of pathogenic T cells, is a potential game changer for the treatment of moderate-to-severe rheumatoid arthritis (RA). In a new Phase 2b clinical trial, rosnilimab ...

Jake Fillery is an Evergreen Editor for Game Rant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

In-hospital mortality among RA-ILD patients during the 20-year study period remained stable but substantial, with 19.5 deaths per 100 admissions in 2022. The retrospective observational study ...

GLP-1 RAs, once thought to reduce the risk of neovascular AMD, appear to actually double it for patients with diabetes. Patients with diabetes who utilize glucagon-like peptide-1 receptor agonists ...

Morning stiffness is common for people with arthritis and that got researchers to thinking that if they could time drug therapy to match the body’s rhythms when pain receptors are most active, they ...

The Arthritis Foundation is funding a study to help predict the onset and progression of interstitial lung disease in rheumatoid arthritis patients. Living with rheumatoid arthritis (RA) often means ...